Skip to content

Optimization of Positron Emission Tomography Computed Tomography Using 68Ga-FAPI in the Diagnosis of Colorectal Cancer Metastases and Monitoring of Antitumor Treatment Efficacy

Sep 2026 · Oncology, Nuclear Medicine and Transplantology · 0 citations

TL;DR

PET/CT using 68Ga-FAPI is a promising imaging modality for colorectal cancer, allowing detection of metastatic and additional suspicious lesions and assessment of dynamic changes during antitumor treatment.

Abstract

Introduction: Colorectal cancer remains one of the leading causes of cancer morbidity and mortality. Timely detection of metastases and assessment of treatment efficacy are important tasks in modern oncology. PET/CT with 18F-FDG has limitations related to physiological uptake of the radiopharmaceutical in the intestine and variable sensitivity across different histological tumor types. The use of 68Ga-FAPI, which has high affinity for tumor stroma and low background uptake, is a promising alternative.  Objective: To evaluate the diagnostic value of PET/CT with 68Ga-FAPI in detecting colorectal cancer metastases and monitoring treatment efficacy. Materials and Methods: The study included 311 patients with histologically verified colorectal cancer examined between January 2024 and January 2026. The study had a retrospective-prospective design. All patients underwent PET/CT using 68Ga-FAPI. Radiopharmaceutical distribution, the presence of metastatic and additional suspicious lesions, as well as dynamic changes during treatment were assessed. Statistical analysis was performed in Microsoft Excel, calculating mean, median, and SUVmax range. The study was approved by the Local Bioethics Committee of the "Astana Medical University" NJSC (Decision No. 11 dated 27.02.2026). Results: The mean age of patients was 58.5 years (range 17–87 years); 171 (55.0%) were women and 140 (45.0%) were men. Adenocarcinoma predominated (87%), predominantly G2; the majority of patients had stage II–III disease. Metastases were detected in 31.2% of patients, most frequently in the liver and lymph nodes; recurrence was observed in 13.0%. Additional suspicious lesions requiring verification were identified in 40% of patients. The mean SUVmax of metastatic lesions was 6.46 (range 1.1–13.8), for recurrence – 5.78 (range 2.6–9.5), and for suspicious lesions – 4.02. Conclusions: PET/CT using 68Ga-FAPI is a promising imaging modality for colorectal cancer, allowing detection of metastatic and additional suspicious lesions and assessment of dynamic changes during antitumor treatment.

View source

Similar papers

Oct 2026

Comprehensive role of fluorine-18-labeled fluorodeoxyglucose PET/computed tomography across the disease course of primary malignant melanoma of the esophagus.

This study aimed to evaluate the clinical value of fluorine-18-labeled fluorodeoxyglucose (18F-FDG) PET/computed tomography (CT) in managing primary malignant melanoma of the esophagus (PMME). Seventy patients with pathologically confirmed PMME between September 2011 and June 2025 were retrospectively analyzed. The dia...

Fei Wang, Xiang-Xi Meng, R. Guo et al. · 0 citations
Open access Oct 2026

The Additional Role of the Quantitative Measurements of 18F-FDG PEM Compared to PET/CT in the Evaluation of Post Interventional Breast Neoplasm

PEM offers superior spatial resolution and provides complementary metabolic information to PET/CT, particularly in small or multifocal lesions, particularly in small or multifocal lesions.

N. Ali, Hashem Mohamed, A. Kandeel et al. · 0 citations
Open access Oct 2026

Diagnostic accuracy of 18F-PSMA-1007 PET/CT and bone scintigraphy for detecting bone metastases in prostate cancer.

OBJECTIVE The performance of 18F-labeled prostate-specific membrane antigen (18F-PSMA-1007) positron emission tomography/computed tomography (PET/CT) and bone scintigraphy (BS) for detecting bone metastases in prostate cancer patients was compared. MATERIALS AND METHODS One hundred prostate cancer patients (initial s...

Kazuhiro Kitajima, Sadahiro Naka, Koji Hatano et al. · 0 citations
Open access Oct 2026

Early Dynamic 18F-FDG PET/CT SUVmax and Its Association with Pathological Stage and Tumor Grade in Bladder Cancer: A Prospective Exploratory Study

Early dynamic 18F-FDG PET/CT imaging at 0–2 min showed the highest, although modest, diagnostic performance among the evaluated time points for predicting tumor grade and muscle invasion.

B. Saylam, Berfin Temelli, Ali Nebi̇oğlu et al. · 0 citations
Open access Oct 2026

Role of 18F-FDG PET/CT and triphasic computed tomography in evaluation of patients with malignant hepatic focal lesions undergoing thermal ablation as local treatment response

Background: Hepatocellular carcinoma (HCC) and liver metastases pose significant diagnostic challenges, particularly regarding early detection of extra-hepatic disease and monitoring post-treatment changes. This prospective study compares the diagnostic performance and prognostic utility of 18F-FDG PET/CT versus contra...

N. Maamoun, Orcid Id · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.